StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1709
This month
17
This week
5
This year
128
Today
1
Yesterday
1
Publishing Date
2023 - 06 - 27
6
2023 - 05 - 15
6
2023 - 05 - 09
6
2023 - 04 - 27
7
2023 - 04 - 20
5
2023 - 02 - 22
5
2023 - 01 - 26
5
2023 - 01 - 09
6
2022 - 12 - 22
5
2022 - 11 - 07
5
2022 - 11 - 03
5
2022 - 08 - 08
7
2022 - 08 - 04
7
2022 - 07 - 28
5
2022 - 07 - 18
7
2022 - 06 - 28
5
2022 - 06 - 20
5
2022 - 06 - 14
5
2022 - 06 - 13
6
2022 - 06 - 07
5
2022 - 06 - 06
7
2022 - 06 - 03
5
2022 - 05 - 11
7
2022 - 04 - 26
7
2022 - 04 - 11
7
2022 - 03 - 01
8
2022 - 02 - 24
6
2022 - 02 - 22
5
2021 - 12 - 13
5
2021 - 12 - 03
5
2021 - 11 - 04
6
2021 - 10 - 18
5
2021 - 10 - 13
5
2021 - 09 - 30
6
2021 - 09 - 28
7
2021 - 09 - 09
5
2021 - 09 - 07
5
2021 - 08 - 18
5
2021 - 08 - 16
6
2021 - 08 - 09
6
2021 - 08 - 03
8
2021 - 07 - 29
6
2021 - 07 - 14
5
2021 - 07 - 09
5
2021 - 06 - 29
6
2021 - 06 - 24
5
2021 - 06 - 22
5
2021 - 06 - 21
5
2021 - 06 - 17
5
2021 - 06 - 08
5
2021 - 06 - 07
6
2021 - 06 - 03
5
2021 - 06 - 01
6
2021 - 05 - 20
5
2021 - 05 - 11
5
2021 - 05 - 04
6
2021 - 04 - 20
7
2021 - 04 - 14
6
2021 - 04 - 13
8
2021 - 04 - 07
7
Sector
Commercial services
13
Communications
8
Consumer durables
1
Consumer non-durables
13
Consumer services
1
Distribution services
6
Electronic technology
13
Finance
21
Finance and insurance
1
Health services
28
Health technology
1709
Industrial services
1
Information
1
Manufacturing
81
N/a
18
Non-energy minerals
1
Process industries
13
Producer manufacturing
7
Professional, scientific, and technical services
22
Retail trade
2
Technology services
15
Transportation
1
Transportation and warehousing
1
Tags
Agreement
25
Alliances
39
Alzheimer's
23
Alzheimer’s
23
Antibody
51
Approval
46
Biomidwest
40
Biopharma
36
Biotech-bay
24
Biotechnology
25
Cancer
139
China
47
Chinese
28
Clinical-trials-phase-iii
32
Collaboration
71
Companies
51
Conference
76
Covid
62
Covid-19
48
Designation
22
Diabetes
57
Disease
89
Drug
105
Earnings
45
Events
32
Expected
24
Fda
71
Financial
65
Financial results
42
Global
149
Growth
108
Health
30
Heart
23
Insulin
37
Iot
23
License
26
Market
306
Meeting
26
Money
34
N/a
1120
Obesity
28
People
70
Pharma
35
Pharmaceutical
24
Phase 1
24
Phase 2
34
Phase 3
47
Positive
30
Report
141
Research
148
Results
203
Risk
24
Study
74
Technology
27
Therapeutics
139
Therapy
88
Tirzepatide
24
Treatment
175
Trial
116
Update
33
Entities
Abbott laboratories
56
Abbvie inc.
111
Abcellera biologics inc
12
Ac immune sa
35
Adc therapeutics sa
13
Agios pharmaceuticals, inc.
10
Akouos, inc.
11
Alnylam pharmaceuticals, inc.
38
Amgen inc.
88
Astellas pharma inc
25
Astrazeneca plc
98
Aveo pharmaceuticals, inc.
25
Baxter international inc.
14
Becton, dickinson and company
21
Beigene, ltd.
19
Biocryst pharmaceuticals, inc.
13
Biogen inc.
20
Biontech se
14
Blueprint medicines corporation
20
Boston scientific corporation
10
Bristol-myers squibb company
106
Clovis oncology, inc.
20
Eli lilly and company
1709
Epizyme, inc.
20
Exelixis, inc.
13
Gilead sciences, inc.
35
Glaxosmithkline plc
107
Hutchison china meditech limited
11
Icon plc
10
Illumina, inc.
15
Incyte corporation
207
Insulet corporation
14
Johnson & johnson
175
Karyopharm therapeutics inc.
20
Ligand pharmaceuticals incorporated
10
Medtronic plc
14
Merus n.v.
21
Nektar therapeutics
10
Novartis ag
138
Novo nordisk a/s
83
Omeros corporation
15
Otonomy, inc.
13
Pfizer, inc.
80
Point biopharma global inc
10
Precision biosciences, inc.
11
Proqr therapeutics n.v.
17
Regeneron pharmaceuticals, inc.
36
Rigel pharmaceuticals, inc.
41
Sanofi
335
Takeda pharmaceutical company limited
42
Terumo corp
14
Teva pharmaceutical industries ltd
61
Thermo fisher scientific inc
14
Ucb s.a.
11
United therapeutics corporation
14
Verastem, inc.
11
Vertex pharmaceuticals incorporated
12
Veru inc.
57
Viatris inc.
18
Y-mabs therapeutics, inc.
18
Symbols
A
429
ABBV
1024
ABT
1787
ALPMF
332
ALPMY
332
AMGN
742
AZN
665
AZNCF
448
BAX
483
BDX
796
BGNE
323
BHC
389
BIIB
381
BIO
449
BMY
662
BNTX
366
BSX
575
BWAY
330
DHR
785
FNCTF
489
GILD
500
GLAXF
658
GMAB
297
GOOG
301
GOOGL
302
GSK
884
HEPA
403
HOLX
328
ILMN
451
INCY
444
JNJ
4583
LLY
1709
MDT
1285
MOR
314
MPSYF
270
MRK
337
MRNA
349
MS
620
NKTR
366
NVO
632
NVS
1241
NVSEF
1031
OCX
482
PFE
692
PHG
962
PKI
274
PRVB
348
QGEN
369
REGN
419
RYLPF
440
SNY
4539
SNYNF
3597
STRO
270
SYK
536
TAK
421
TEVJF
631
TMO
1622
TXMD
278
VTRS
364
VXRT
314
Exchanges
Amex
5
Nasdaq
1088
Nyse
1709
Crawled Date
2023 - 10 - 04
5
2023 - 10 - 02
5
2023 - 07 - 25
5
2023 - 07 - 17
5
2023 - 06 - 27
6
2023 - 06 - 26
5
2023 - 05 - 15
6
2023 - 05 - 09
6
2023 - 05 - 03
5
2023 - 04 - 27
5
2023 - 04 - 20
5
2023 - 02 - 28
5
2023 - 01 - 26
5
2023 - 01 - 09
6
2022 - 12 - 22
5
2022 - 11 - 07
5
2022 - 08 - 08
7
2022 - 08 - 04
7
2022 - 07 - 28
5
2022 - 07 - 18
6
2022 - 06 - 20
5
2022 - 06 - 14
5
2022 - 06 - 13
6
2022 - 06 - 07
6
2022 - 06 - 06
7
2022 - 06 - 03
5
2022 - 05 - 11
7
2022 - 04 - 26
7
2022 - 04 - 11
8
2022 - 03 - 01
8
2022 - 02 - 22
5
2021 - 12 - 13
5
2021 - 12 - 03
5
2021 - 11 - 04
5
2021 - 10 - 18
5
2021 - 10 - 13
5
2021 - 09 - 30
6
2021 - 09 - 28
7
2021 - 09 - 09
5
2021 - 09 - 07
5
2021 - 08 - 18
5
2021 - 08 - 16
6
2021 - 08 - 09
7
2021 - 08 - 03
8
2021 - 07 - 29
6
2021 - 07 - 14
5
2021 - 07 - 09
5
2021 - 06 - 29
6
2021 - 06 - 24
5
2021 - 06 - 22
6
2021 - 06 - 08
5
2021 - 06 - 07
6
2021 - 06 - 01
5
2021 - 05 - 20
5
2021 - 05 - 11
5
2021 - 05 - 04
6
2021 - 04 - 20
7
2021 - 04 - 14
6
2021 - 04 - 13
10
2021 - 04 - 07
7
Crawled Time
00:00
74
00:01
1
00:20
9
01:00
112
01:15
1
02:00
23
02:11
1
03:00
13
04:00
5
04:20
9
05:00
13
06:00
11
07:00
13
08:00
22
09:00
19
10:00
31
10:51
1
11:00
111
11:36
1
12:00
173
12:03
2
12:07
5
12:09
2
12:10
1
12:11
7
12:15
19
12:20
29
12:30
19
12:34
1
12:39
1
12:40
1
13:00
100
13:01
1
13:07
1
13:15
8
13:20
25
13:30
11
14:00
77
14:15
8
14:20
11
14:30
18
15:00
84
15:15
3
15:20
22
15:30
19
16:00
95
16:20
11
17:00
67
18:00
60
18:17
2
18:31
2
19:00
53
19:11
2
20:00
46
20:20
3
21:00
93
22:00
70
22:04
2
23:00
52
23:07
2
Source
brightmindsbio.com
1
investor.alkermes.com
2
investor.aveooncology.com
2
ir.cyclerion.com
1
ir.pulmatrix.com
1
ir.vaccinex.com
1
www.aspenpharma.com
2
www.biospace.com
589
www.brickellbio.com
2
www.chi-med.com
1
www.clarivate.com
1
www.concertpharma.com
1
www.cowen.com
1
www.emmis.com
1
www.fda.gov
37
www.firstbankonline.com
1
www.globenewswire.com
200
www.hutch-med.com
2
www.precisionbiosciences.com
2
www.preludetx.com
1
www.prnewswire.com
859
www.thermogenesis.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
symbols :
Lly
save search
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published:
2024-04-19
(Crawled : 15:00)
- prnewswire.com
NVO
|
$122.69
-0.05%
3.8M
|
Health Technology
|
0.0%
|
O:
-0.75%
H:
0.0%
C:
0.0%
GSK
|
$39.585
0.8%
1.1M
|
Health Technology
|
0.0%
|
O:
-0.56%
H:
0.0%
C:
0.0%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
0.0%
|
O:
-0.21%
H:
0.0%
C:
0.0%
AZN
|
$68.41
0.07%
2.9M
|
Health Technology
|
0.0%
|
O:
-0.15%
H:
0.0%
C:
0.0%
report
reach
therapeutics
market
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
Published:
2024-04-17
(Crawled : 20:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
0.0%
|
O:
0.0%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.545
2.55%
2.3M
|
Health Technology
|
-1.81%
|
O:
-1.81%
H:
0.0%
C:
0.0%
biotech
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
Published:
2024-04-17
(Crawled : 11:00)
- biospace.com/
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-0.09%
|
O:
1.03%
H:
1.66%
C:
-1.11%
obesity
tirzepatide
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
Published:
2024-04-16
(Crawled : 15:00)
- biospace.com/
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
0.0%
|
O:
0.09%
H:
0.0%
C:
0.0%
announcement
conference
for
financial
results
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
Published:
2024-04-15
(Crawled : 20:00)
- globenewswire.com
CRGX
|
$19.195
0.5%
60K
|
|
0.55%
|
O:
-1.76%
H:
6.0%
C:
2.35%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
0.0%
|
O:
0.09%
H:
0.0%
C:
0.0%
BDTX
A
|
$5.185
-2.17%
210K
|
Health Technology
|
3.07%
|
O:
0.57%
H:
2.86%
C:
2.48%
AUTL
|
$4.635
-3.44%
740K
|
Health Technology
|
-0.82%
|
O:
0.0%
H:
2.04%
C:
-0.82%
therapeutics
Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 | DelveInsight
Published:
2024-04-11
(Crawled : 22:00)
- prnewswire.com
ALPMF
|
$9.17
16K
|
Health Technology
|
-7.3%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ALPMY
|
$9.47
520K
|
Manufacturing
|
-9.23%
|
O:
-8.65%
H:
3.19%
C:
1.6%
JNJ
|
News
|
$147.6
1.28%
5.6M
|
Health Technology
|
-3.82%
|
O:
-1.65%
H:
0.0%
C:
0.0%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-1.16%
|
O:
-0.0%
H:
0.52%
C:
-1.04%
growth
market
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
Published:
2024-04-11
(Crawled : 05:00)
- globenewswire.com
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-0.14%
|
O:
1.06%
H:
0.47%
C:
-0.03%
fda
device
disease
test
granted
blood
designation
for
alzheimer's
roche
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published:
2024-04-10
(Crawled : 22:00)
- biospace.com/
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-0.85%
|
O:
-0.71%
H:
0.0%
C:
0.0%
drug
preclinical
meeting
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
Published:
2024-04-09
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
TMO
|
News
|
$543.895
0.44%
830K
|
Health Technology
|
-9.54%
|
O:
-2.01%
H:
0.0%
C:
0.0%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-0.85%
|
O:
-0.71%
H:
0.0%
C:
0.0%
BIO
|
News
|
$279.16
-0.66%
200K
|
Health Technology
|
-19.64%
|
O:
-2.71%
H:
0.52%
C:
0.24%
AVTR
|
$24.18
-0.49%
2.7M
|
Process Industries
|
-4.87%
|
O:
-1.7%
H:
1.08%
C:
0.55%
THMO
|
$0.6695
3.0%
8.5K
|
Health Technology
|
-24.22%
|
O:
4.99%
H:
2.78%
C:
-2.1%
SNY
|
News
|
$46.545
2.55%
2.3M
|
Health Technology
|
-4.25%
|
O:
-0.32%
H:
0.0%
C:
0.0%
global
growth
market
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Published:
2024-04-09
(Crawled : 20:00)
- globenewswire.com
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-0.85%
|
O:
-0.71%
H:
0.0%
C:
0.0%
ORIC
|
$8.87
-6.73%
230K
|
Health Technology
|
-8.53%
|
O:
-2.81%
H:
1.54%
C:
-3.57%
NRIX
2 d
|
$13.4
-7.2%
340K
|
Health Technology
|
2.52%
|
O:
18.35%
H:
1.98%
C:
-5.88%
therapeutics
Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
Published:
2024-04-08
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$147.6
1.28%
5.6M
|
Health Technology
|
-4.51%
|
O:
-0.3%
H:
0.0%
C:
0.0%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-3.41%
|
O:
0.05%
H:
0.02%
C:
-2.62%
MOR
|
$17.94
-0.61%
110K
|
Health Technology
|
-0.55%
|
O:
0.06%
H:
0.22%
C:
0.0%
KNSA
|
$16.83
-0.3%
160K
|
Health Technology
|
-4.52%
|
O:
0.23%
H:
1.58%
C:
0.06%
IMAB
|
$1.805
0.28%
280K
|
Health Technology
|
-0.55%
|
O:
-0.55%
H:
1.39%
C:
0.0%
GLPG
|
$28.905
-0.02%
44K
|
Health Technology
|
-8.29%
|
O:
0.0%
H:
0.39%
C:
-0.66%
positive
growth
market
AMERICAN SKIN ASSOCIATION SPRING GALA CELEBRATES OUTSTANDING HONOREES
Published:
2024-04-05
(Crawled : 23:00)
- prnewswire.com
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
Email alert
Add to watchlist
association
spring
skin
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
Published:
2024-04-05
(Crawled : 12:30)
- globenewswire.com
IOBT
|
$1.47
86K
|
|
-12.28%
|
O:
-0.58%
H:
0.0%
C:
-5.88%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-3.94%
|
O:
-2.06%
H:
2.77%
C:
2.45%
biotech
business
The Top 11 Companies Hiring in Biopharma Now
Published:
2024-04-04
(Crawled : 05:00)
- biospace.com/
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-2.46%
|
O:
1.53%
H:
0.0%
C:
0.0%
companies
biopharma
Blacksmith Medicines to Present at the 23rd Annual Needham Healthcare Conference
Published:
2024-04-03
(Crawled : 15:00)
- biospace.com/
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-1.73%
|
O:
0.76%
H:
0.0%
C:
0.0%
conference
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published:
2024-04-02
(Crawled : 05:00)
- prnewswire.com
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-3.34%
|
O:
-2.79%
H:
1.32%
C:
1.18%
SNY
|
News
|
$46.545
2.55%
2.3M
|
Health Technology
|
-6.67%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
review
cancer
treatment
advanced
china
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published:
2024-04-02
(Crawled : 05:00)
- globenewswire.com
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-3.34%
|
O:
-2.79%
H:
1.32%
C:
1.18%
SNY
|
News
|
$46.545
2.55%
2.3M
|
Health Technology
|
-6.67%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
HCM
|
$16.44
0.49%
28K
|
Health Technology
|
-1.47%
|
O:
0.21%
H:
1.49%
C:
-0.06%
treatment
advanced
china
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published:
2024-03-28
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
$20.2
510
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.6
1.28%
5.6M
|
Health Technology
|
-7.14%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
$39.585
0.8%
1.1M
|
Health Technology
|
-7.89%
|
O:
0.02%
H:
0.51%
C:
-0.3%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-3.52%
|
O:
0.28%
H:
1.71%
C:
-0.3%
BMY
|
$48.89
1.22%
5.1M
|
Health Technology
|
-9.3%
|
O:
0.26%
H:
2.03%
C:
1.57%
AMGN
|
$267.41
1.77%
1.4M
|
Health Technology
|
-7.46%
|
O:
0.54%
H:
0.0%
C:
0.0%
antibody
research
global
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
Published:
2024-03-28
(Crawled : 12:00)
- biospace.com/
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-3.52%
|
O:
0.28%
H:
1.71%
C:
-0.3%
business
year
financial
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published:
2024-03-27
(Crawled : 20:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ERAS
|
$1.74
-2.79%
380K
|
|
-6.31%
|
O:
17.48%
H:
6.94%
C:
-14.88%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-3.52%
|
O:
0.28%
H:
1.71%
C:
-0.3%
business
year
financial
results
← Previous
1
2
3
4
5
6
7
8
9
…
85
86
Next →
Gainers vs Losers
71%
29%
Top 10 Gainers
AGBA
|
News
|
$1.27
217.5%
120M
|
Finance
EGOX
|
$0.0503
39.72%
320M
|
RWOD
|
$10.52
31.56%
5.9M
|
n/a
ZCMD
|
$1.905
31.38%
30M
|
Commercial Services
MRDB
4
|
$0.536
27.65%
2M
|
n/a
BSFC
|
$0.0822
27.64%
75M
|
Manufacturing
TPET
|
$0.4121
25.68%
45M
|
n/a
NVFY
|
$2.65
25.59%
33M
|
Consumer Durables
INDO
|
$5.1
25.0%
15M
|
Energy Minerals
CHRO
|
$1.53
24.9%
100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.